Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?

Ahmed Naguy

Journal: Journal of dietary supplements 2018;15(1):124-128

PMID: 28558251

Abstract

Use of omega-3 in psychiatric practice is on the rise. It has been used in diverse indications, notably mood disorders, schizophrenia, dementia, borderline personality, and neurodevelopmental disorders, with varying levels of evidence base. Here, the author sheds some light on the therapeutic potential of omega-3 as an appealing addition to psychopharmacological armamentarium.

Address: a Kuwait Centre for Mental Health , Al-Manara CAP Centre , Shuwaikh , Kuwait.

DOI: 10.1080/19390211.2017.1326432

Link outs

Free resources

Medical:

https://medlineplus.gov/mentaldisorders.html

Other Literature Sources:

https://scite.ai/reports/28558251

Subscription / membership required

Full Text Sources:

https://www.tandfonline.com/doi/10.1080/19390211.2...

MeSH Terms: Borderline Personality Disorder, Dementia, Evidence-Based Medicine, Fatty Acids, Omega-3, Humans, Mental Disorders, Mood Disorders, Neurodevelopmental Disorders, Psychotropic Drugs, Schizophrenia